Coral Laboratories Limited (BOM:524506)
556.15
-25.80 (-4.43%)
At close: Jul 27, 2026
Coral Laboratories Market Cap
Coral Laboratories has a market cap or net worth of 2.06 billion as of July 28, 2026. Its market cap has increased by 0.58% in one year.
Market Cap
2.06B
Enterprise Value
1.09B
Revenue
859.00M
Ranking
n/a
PE Ratio
12.58
Stock Price
556.15
ChartMarket Cap Chart
Since August 4, 1998, Coral Laboratories's market cap has increased from 39.30M to 2.06B, an increase of 5,143.18%. That is a compound annual growth rate of 15.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 1.99B | 26.83% |
| Dec 31, 2025 | 1.57B | -42.52% |
| Dec 31, 2024 | 2.73B | 75.31% |
| Dec 29, 2023 | 1.55B | 35.01% |
| Dec 30, 2022 | 1.15B | 3.55% |
| Dec 31, 2021 | 1.11B | 0.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Astonea Labs | 2.85B |
| Ambalal Sarabhai Enterprises | 2.44B |
| Gennex Laboratories | 2.17B |
| Sat Kartar Life | 2.00B |
| Kerala Ayurveda | 1.98B |
| Oxygenta Pharmaceutical | 1.93B |
| Sanjivani Paranteral | 1.85B |
| Bio Medica Laboratories | 1.78B |